Dr Janak de Zoysa

Selected publications and creative works (Research Outputs)

  • HONEYPOT Trial Writing Committee, Zhang, L., Badve, S. V., Pascoe, E. M., Beller, E., Cass, A., ... Liu, X. (2017). Representativeness of Honeypot Trial Participants to Australasian PD Patients. Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 37 (5), 516-522. 10.3747/pdi.2016.00065
  • Jardine, M. J., Zuo, L., Gray, N. A., de Zoysa, J. R., Chan, C. T., Gallagher, M. P., ... Lin, H. (2017). A Trial of Extending Hemodialysis Hours and Quality of Life. Journal of the American Society of Nephrology : JASN, 28 (6), 1898-1911. 10.1681/ASN.2015111225
  • Puckett, J. R., Pickering, J. W., Palmer, S. C., McCall, J. L., Kluger, M. T., De Zoysa, J., ... Soop, M. (2017). Low Versus Standard Urine Output Targets in Patients Undergoing Major Abdominal Surgery: A Randomized Noninferiority Trial. Annals of surgery, 265 (5), 874-881. 10.1097/sla.0000000000002044
  • Hsiao, C.-Y., Pilmore, H. L., Zhou, L., & de Zoysa, J. R. (2016). Outcomes of renal transplant recipients with BK virus infection and BK virus surveillance in the Auckland region from 2006 to 2012. World journal of nephrology, 5 (6), 497-506. 10.5527/wjn.v5.i6.497
  • Miller, H. M., Tong, A., Tunnicliffe, D. J., Campbell, D., Pinter, J., Commons, R. J., ... Green, J. (2016). Identifying and integrating patient and caregiver perspectives for clinical practice guidelines on the screening and management of infectious microorganisms in hemodialysis units. Hemodialysis International10.1111/hdi.12457
  • Brigandi, R. A., Johnson, B., Oei, C., Westerman, M., Olbina, G., de Zoysa, J., ... McMahon, L. (2016). A Novel Hypoxia-Inducible Factor−Prolyl Hydroxylase Inhibitor (GSK1278863) for Anemia in CKD: A 28-Day, Phase 2A Randomized Trial. American Journal of Kidney Diseases, 67 (6), 861-871. 10.1053/j.ajkd.2015.11.021
  • Zhang, L., Liu, X., Pascoe, E. M., Badve, S. V., Boudville, N. C., Clayton, P. A., ... McDonald, S. P. (2016). Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: A multi-centre registry study. Nephrology (Carlton, Vic.), 21 (5), 387-396. 10.1111/nep.12629
  • Bloomfield, K., de Zoysa, J., & Dixon, S. (2016). The Prevalence of Frailty In New Zealand Dialysis Patients Using the Edmonton Frailty Scale and Fried Frailty Scale. Paper presented at International Conference on Frailty and Sarcopenia Research, Philadelphia, US. 28 April - 29 April 2016. The Journal of Frailty and Aging, vol.5, supp.1.
    Other University of Auckland co-authors: Katherine Bloomfield

Contact details

Primary office location

Level 1, Room 1002
New Zealand